Atea Pharmaceuticals Starts Phase 1 AT-587 Trial
BOSTON, July 14, 2026 Atea Pharmaceuticals announced the initiation of a first-in-human Phase 1 clinical trial evaluating AT-587, an...
HEV
Advertisement
Mestag Therapeutics Doses First Patient in STARLYS Trial of MST-0312 for Solid Tumors
CAMBRIDGE, UK, May 19, 2026 Mestag Therapeutics announced the first patient has been dosed in the Phase 1 STARLYS...
Advertisement
